[
    [
        {
            "time": "2018-12-10~2018-12-16",
            "original_text": "每周医药生物行业机构观点选编（2018年12月10日~12月16日）",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "机构观点",
                    "政策"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "每周医药生物行业机构观点选编（2018年12月10日~12月16日）",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-12-17",
            "original_text": "12月17日 主力资金抢筹最积极的前10股（附名单）",
            "features": {
                "keywords": [
                    "主力资金",
                    "抢筹",
                    "股票名单"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "12月17日 主力资金抢筹最积极的前10股（附名单）",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-12-17",
            "original_text": "市场 | 创新药、仿制药，冰火两重天",
            "features": {
                "keywords": [
                    "创新药",
                    "仿制药",
                    "市场对比"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "市场 | 创新药、仿制药，冰火两重天",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-17",
            "original_text": "医药生物行业：国家级辅助用药目录将出台,医保转移利好刚性用药企业",
            "features": {
                "keywords": [
                    "医药生物",
                    "政策",
                    "辅助用药",
                    "医保",
                    "刚性用药"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "医药生物行业：国家级辅助用药目录将出台,医保转移利好刚性用药企业",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-17",
            "original_text": "北上资金周流入放缓 消费和基建龙头受青睐",
            "features": {
                "keywords": [
                    "北上资金",
                    "消费",
                    "基建",
                    "龙头"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "基建"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金周流入放缓 消费和基建龙头受青睐",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-17",
            "original_text": "A股低位震荡不改“聪明资金”流向 24股上演建仓大戏",
            "features": {
                "keywords": [
                    "A股",
                    "低位震荡",
                    "聪明资金",
                    "建仓"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股低位震荡不改“聪明资金”流向 24股上演建仓大戏",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-17",
            "original_text": "医药生物行业周报:政策多发扰动期,建议关注品牌中药的配置价值",
            "features": {
                "keywords": [
                    "医药生物",
                    "政策",
                    "品牌中药",
                    "配置价值"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "医药生物行业周报:政策多发扰动期,建议关注品牌中药的配置价值",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]